NAX4 is the largest private equity fund raised that focuses on investing solely in North America.

The Fund materially surpassed its €1bn target owing to strong demand from a globally diverse group of investors including sovereign wealth funds, pension funds, insurance companies and asset managers.

Fund VII was heavily oversubscribed with demand from a globally diverse range of leading institutional investors, including pension funds, sovereign wealth funds, insurance firms, asset managers, endowments, foundations, wealth managers and family offices.

It is the largest life sciences private fund ever raised and is nearly 40% larger than its predecessor vehicle.

Pictet Alternative Advisors (“Pictet”) has announced the final close of Pictet Private Equity Entrepreneur Capital I (“Entrepreneur Capital” or the “Fund”), its first direct private equity strategy, at €403m. The LP base includes foundations, pension funds, institutional family offices and entrepreneurs.

A top executive at the PE firm told Business Standard that the third fund exceeded its earlier target of $250 million. The additional capital is expected to enable the fund to support larger and more scalable opportunities.

Lead Edge will target making private equity investments between $50 million to $400 million per portfolio company, targeting software, internet, and technology-enabled businesses.

The oversubscribed fund was supported by a concentrated base of existing limited partners and strong interest from new institutional investors, technology company founders, and executives.

The fund closed with around US$2.2 billion, making it Orion’s largest fund to date, with firm commitments from a diversified global investor base.

Launched by a first‑time team in one of the most challenging fundraising environments of the past decade, the fund’s closing represents a significant vote of confidence from the international LP community and marks one of the largest debut impact franchise launches in Europe in recent years.

The fund was raised from a diversified group of institutional investors, family offices and registered investment advisors. Canopy Fund I targets value-add multifamily, industrial and retail assets in Western U.S. markets where refinancing pressure and reduced liquidity have created acquisition opportunities.

The Fund has raised capital from new and existing investors globally, underscoring the continued confidence of Limited Partners in Triton’s European mid-market strategy and the Firm’s ability to build better businesses.

DIF III is Eagle Point’s third closed-end fund in its Defensive Income Fund series.

PCP I closed above its original €400 million fundraising objective with c.€540 million of investor capital, reflecting the growing investor demand for this investment strategy and for BNPP AM Alts’ differentiated approach to GP Stakes. It represents to date the largest GP stakes fund raised by a European manager.

ISCP II closed at a size more than 75% higher than that of ISCP I in a highly selective fundraising environment for private markets, underscoring the differentiated nature of ISCG’s strategy and the strength of its LP relationships. Following the ISCP II fundraise, ISCG AUM totals over $2.4 billion.

Launched in Q4 2025, Fund V was raised in just over four months. Returning limited partners committed the substantial majority of capital to the Fund, while the Firm welcomed a select number of new institutional investors to its close-knit LP base.

Fund V’s investor base includes global public and private pension funds, sovereign wealth funds, insurance companies, family offices, and other institutional investors. Along with strong support from existing investors, the Fund welcomed a broad set of new investors. Prior to the final close, Fund V invested in four platform companies: Equity Methods, Sterling Brokers, Inspired PLC, and Centralis Group.

Ascend Fund II drew commitments from public and private pension funds, foundations, endowments, consultants, family offices, and funds of funds. The firm's inaugural fund closed at its $570 million hard cap in December 2021 and has been fully deployed across eight investments.

The Fund was raised in under a year, quickly exceeding its target of US$2.75 billion by over $1 billion, highlighting Novacap’s longstanding focus on disciplined, value-added technology buyouts. With the close of Tech VII – the latest fund in Novacap’s Technologies strategy, one of the Firm’s four sector-focused private equity buyout strategies – Novacap now manages more than US$12 billion in assets.

The Fund received strong support from an investor base comprised of both longstanding and new limited partners spanning the institutional spectrum.